T

TAK

TAK

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
TAK Live QuoteReal-time
$21.79
+$1.86(+9.31%)1M
Day Range$21.74 – $22.07
Open$21.85
Previous Close$21.41
Volume3.80M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$68.40B
P/E Ratio (TTM)305.9
Forward P/E13.0
EPS (TTM)$0.07
Price to Book1.5
Dividend Yield2.90%
Beta (Volatility)0.08
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
52-Week RangeCurrent: $21.79 (99%)
Low: $13.63High: $21.86
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$24.59-83.6% upside

Insider Buys

0

$0

Insider Sales

20

$14.25M

Total Volume

$14.25M

26 transactions

Net Activity

$14.25M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
P
1

Plump Andrew Stewart

Pres, R, D

0 buys3 sells

$5.34M total

P
2

Platford Giles Richard

Pres, IBU

0 buys2 sells

$1.69M total

K
3

Kim Julie So-Young

Pres, CEO

0 buys1 sells

$1.52M total

D
4

Duprey Lauren Rusckowski

Chief Transformation Officer

0 buys2 sells

$1.45M total

G
5

Greenway Nicola Deidre Petal

CHRO

0 buys3 sells

$957K total

Trading History
TAK insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 4, 2026

2 weeks ago

Platford Giles Richard

Pres, IBU

President
Sell55.6K$20.90$1.16M

Sep 14, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell191.5K$-34535.00$0

Sep 14, 2026

2 months ago

Duprey Lauren Rusckowski

Chief Transformation Officer

C-Level
Sell34.5K$18.54$640K

Sep 2, 2026

2 months ago

Plump Andrew Stewart

Pres, R, D

President
Sell116.2K$18.49$2.15M

Sep 2, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell912.0K$-116191.00$0

Aug 19, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.03M$-19651.00$0

Aug 19, 2026

3 months ago

Plump Andrew Stewart

Pres, R, D

President
Sell19.7K$18.49$363K

Aug 18, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell40.0K$-12980.00$0

Aug 18, 2026

3 months ago

Greenway Nicola Deidre Petal

CHRO

C-Level
Sell13.0K$18.11$235K

Aug 10, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell116.2K$-14006.00$0

Aug 10, 2026

3 months ago

Farajallah Awny Samaan Botros

Chief Medical Officer

C-Level
Sell14.0K$17.10$240K

Aug 10, 2026

3 months ago

Ibrahim Ramy Riad Ahmed

Pres, PDT BU

President
Sell7.3K$17.10$124K

Aug 10, 2026

3 months ago

Pacheco Rhonda Janice

Pres, U.S. Business Unit

President
Sell16.9K$17.10$289K

Aug 10, 2026

3 months ago

Duprey Lauren Rusckowski

Chief Transformation Officer

C-Level
Sell47.6K$17.10$814K

Aug 10, 2026

3 months ago

Plump Andrew Stewart

Pres, R, D

President
Sell165.4K$17.10$2.83M

Aug 10, 2026

3 months ago

Pignagnoli Agosti Marcello

Head, Strat., Port. Dev

Insider
Sell23.0K$17.10$393K

Aug 10, 2026

3 months ago

Bitetti Teresa Marie

Pres, OBU

President
Sell50.0K$17.10$855K

Aug 10, 2026

3 months ago

Shannon Elaine Mary

Pres, Global Supply, Quality

President
Sell4.0K$17.10$68K

Aug 10, 2026

3 months ago

Ricci Gabriele

Chief Data, Tech. Officer

C-Level
Sell25.1K$17.10$429K

Aug 10, 2026

3 months ago

Greenway Nicola Deidre Petal

CHRO

C-Level
Sell6.8K$17.10$116K

Aug 10, 2026

3 months ago

Kim Julie So-Young

Pres, CEO

CEO
Sell89.1K$17.10$1.52M

Aug 10, 2026

3 months ago

Platford Giles Richard

Pres, IBU

President
Sell31.1K$17.10$532K

Aug 10, 2026

3 months ago

Furney Natalie Anne Marie

Global GC

General Counsel
Sell30.9K$17.10$528K

Aug 11, 2026

3 months ago

Shannon Elaine Mary

Pres, Global Supply, Quality

President
Sell20.4K$17.55$357K

Aug 10, 2026

3 months ago

Greenway Nicola Deidre Petal

CHRO

C-Level
Sell34.6K$17.51$606K

Aug 11, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell67.3K$-20363.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
TAK Buy Conviction0%
Industry Rank#324 of 569
Volume Contribution0.1%
Total Industry Activity$16.52B

TAK has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. TAK ranks #324 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for TAK

Over the last 90 days, corporate insiders at TAK (TAK) engaged in a total of 26 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 20 were sales. The total volume of insider trading reached $14.25M.

The net insider activity for TAK shows a net selling bias of $14.25M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Plump Andrew Stewart (Pres, R, D), who traded 165.4K shares valued at $2.83M on Aug 10, 2026.

Live Market News & Developments
Aggregated real-time headlines for TAK (TAK)
6 updates

Takeda Pharmaceutical Company Limited (TAK) Stock Price, News, Quote & History

Yahoo! Finance CanadaYesterday

Takeda Pharmaceutical Company Stock Price Forecast. Should You Buy TAK?

StockInvest.us3d ago

Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and history

Yahoo Finance SingaporeYesterday

Takeda Pharmaceutical (NYSE:TAK) Stock Forecast & Analyst Predictions

Simply Wall St3d ago

TAK - Takeda Pharmaceutical Co ADR Stock Price and Quote

Finviz177d ago

Takeda Pharmaceutical Co. (TAK) Stock Price Prediction for 2026, 2030-2040

Traders Union34d ago

FAQs About TAK Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for TAK.

Based on SEC Form 4 disclosures, the Insider Confidence Score for TAK is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 20 sales by company executives over the last 90 days.

The CEO Conviction Index for TAK is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.